Metabolic dysfunction-associated steatohepatitis (MASH) is a liver condition where fat builds up in the liver, causing inflammation and damage. Unlike liver issues caused by alcohol, MASH is linked to problems like obesity, diabetes, and high cholesterol. If left untreated, MASH can…
Resmetirom: A Promising New Frontier in MASH Therapy
Fatty liver, an increasing global health concern Metabolic dysfunction-associated steatotic liver disease (MASLD), commonly referred to as fatty liver disease, is becoming a global health concern, with over 30% of adults affected. In regions like South America and the Middle East,…
The Hidden Struggle: How Fibrosis is Redefining the Future of MASH Management (Metabolic Dysfunction-Associated Steatohepatitis)
Imagine your body as a bustling city where everything works seamlessly, maintaining the delicate balance of health. Now, think of non-alcoholic steatohepatitis (NASH) or Metabolic dysfunction-associated steatohepatitis (MASH) as an insidious construction project gone wrong inside this city, gradually laying down…
Diabetes Researchers Find Switch for Fatty Liver Disease
Duke researchers have identified a key fork in the road for the way the liver metabolism deals with carbohydrates, fats, and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and prediabetes….